向移植耐受性倾斜平衡:使用突变IL-2的体内治疗
The Journal of clinical investigation
|March 1, 2024
概括
工程IL-2疗法 (mIL-2-Fc) 在多种物种中增加了调节性T细胞 (Treg) 数量. 这种方法促进了移植耐受性,并可能增强目前的免疫抑制治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 移植免疫学 移植免疫学
- 免疫治疗是一种免疫疗法.
背景情况:
- 实现对异种移植组织的免疫耐受性是移植的一个重大挑战.
- 调节性T细胞 (Tregs),特别是CD4+FOXP3+Tregs,对于免疫耐受性至关重要.
研究的目的:
- 开发和评估一种用于增强Treg功能和促进移植耐受性的新疗法.
主要方法:
- 设计了一个Fc域与人类突变蛋白IL-2 (mIL-2-Fc) 融合,具有突变,可优先结合Tregs上的高亲和度IL-2受体.
- 在小鼠,子和人类细胞体内给予mIL-2-Fc治疗.
主要成果:
- mIL-2-Fc治疗显著增加了小鼠,子和人类系统中的Treg数量.
- 该疗法促进了小鼠对抗原不匹配的轻微皮肤移植的耐受性.
- mIL-2-Fc与临床使用的免疫抑制药物展现了协同作用.
结论:
- 改造的mIL-2-Fc是一种有前途的治疗策略,用于增强Treg种群和促进异构移植耐受性.
- 这些发现支持在移植环境中对mIL-2-Fc的临床评估.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330


